Biomarker | Univariate model | Multivariable model |
---|
HR (95%CI) | Pfdr | HR (95%CI) | Pfdr |
---|
Total NT-proBNP | 1.15 (1.02–1.30) | 0.040 | 1.19 (1.04–1.36) | 0.026 |
NT-proBNP | 1.21 (1.09–1.34) | 0.002 | 1.19 (1.06–1.35) | 0.016 |
Ang2 | 1.15 (1.01–1.30) | 0.047 | 1.07 (0.95–1.20) | 0.283 |
BMP10 | 1.01 (0.88–1.17) | 0.898/ | 1.09 (0.96–1.25) | 0.249 |
- The prediction of AF recurrence was assessed by Cox proportional hazards regression models. Data shown as hazard ratio HR for an increment of 1 SD of baseline biomarker value. The multivariable model was adjusted for sex and > 2 episodes of AF in the six months before inclusion in the GISSI-AF trial. P-value was corrected for multiple testing by means of FDR-correction. HR, hazard ratio; NT-proBNP, N-terminal pro-B type natriuretic peptide; Ang2, angiopoietin 2; BMP10, bone morphogenic protein-10